BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15999693)

  • 1. [Role of mitochondrial dysfunction in pathogenesis of diabetic microangiopathy].
    Suzuki S
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():103-10. PubMed ID: 15999693
    [No Abstract]   [Full Text] [Related]  

  • 2. Beware the thin, deaf 'type 2' diabetic: maternally inherited diabetes and deafness with systemic (mitochondrial) manifestations.
    Jones DL; Greenaway TM
    Intern Med J; 2004 Aug; 34(8):517-8. PubMed ID: 15317555
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug therapy for mitochondrial diseases].
    Kuroda Y; Naito E; Touda Y
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():670-3. PubMed ID: 12013970
    [No Abstract]   [Full Text] [Related]  

  • 4. Coenzyme Q10 and diabetic endotheliopathy: oxidative stress and the 'recoupling hypothesis'.
    Chew GT; Watts GF
    QJM; 2004 Aug; 97(8):537-48. PubMed ID: 15256611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mitochondrial dysfunction in migraine].
    Yoneda M
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():519-21. PubMed ID: 12013930
    [No Abstract]   [Full Text] [Related]  

  • 6. Mitochondrial respiratory chain dysfunction caused by coenzyme Q deficiency.
    Rustin P; Munnich A; Rötig A
    Methods Enzymol; 2004; 382():81-8. PubMed ID: 15047097
    [No Abstract]   [Full Text] [Related]  

  • 7. [Definition and classification of mitochondrial diseases].
    Goto Y
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():213-7. PubMed ID: 12013850
    [No Abstract]   [Full Text] [Related]  

  • 8. [Oxidative stress and its prevention in mitochondria].
    Dongchon K
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():181-6. PubMed ID: 12013846
    [No Abstract]   [Full Text] [Related]  

  • 9. [Oxidative damage, maintenance, and higher structure of mitochondrial DNA].
    Kang D
    Tanpakushitsu Kakusan Koso; 2005 Apr; 50(4):316-21. PubMed ID: 15828277
    [No Abstract]   [Full Text] [Related]  

  • 10. Pro-oxidant mitochondrial matrix-targeted ubiquinone MitoQ10 acts as anti-oxidant at retarded electron transport or proton pumping within Complex I.
    Plecitá-Hlavatá L; Jezek J; Jezek P
    Int J Biochem Cell Biol; 2009; 41(8-9):1697-707. PubMed ID: 19433311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic microangiopathy: physiopathological, clinical and therapeutic aspects.
    Camera A; Hopps E; Caimi G
    Minerva Endocrinol; 2007 Sep; 32(3):209-29. PubMed ID: 17912158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ubiquinone: metabolism and functions. Ubiquinone deficiency and its implication in mitochondrial encephalopathies. Treatment with ubiquinone].
    Artuch R; Colomé C; Vilaseca MA; Pineda M; Campistol J
    Rev Neurol; 1999 Jul 1-15; 29(1):59-63. PubMed ID: 10528314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical studies on mitochondrial diseases].
    Goto Y
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():4-6. PubMed ID: 12013897
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ophthalmoplegia].
    Terada M; Mitsunami K; Maeda K; Yasuda H
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():522-5. PubMed ID: 12013931
    [No Abstract]   [Full Text] [Related]  

  • 15. Electron transfer mediators and other metabolites and cofactors in the treatment of mitochondrial dysfunction.
    Orsucci D; Filosto M; Siciliano G; Mancuso M
    Nutr Rev; 2009 Aug; 67(8):427-38. PubMed ID: 19674340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.
    Haas RH
    Mitochondrion; 2007 Jun; 7 Suppl():S136-45. PubMed ID: 17485245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial respiratory dysfunction-elicited oxidative stress and posttranslational protein modification in mitochondrial diseases.
    Wu YT; Wu SB; Lee WY; Wei YH
    Ann N Y Acad Sci; 2010 Jul; 1201():147-56. PubMed ID: 20649551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coenzyme Q10 deficiency associated with a mitochondrial DNA depletion syndrome: a case report.
    Montero R; Sánchez-Alcázar JA; Briones P; Navarro-Sastre A; Gallardo E; Bornstein B; Herrero-Martín D; Rivera H; Martin MA; Marti R; García-Cazorla A; Montoya J; Navas P; Artuch R
    Clin Biochem; 2009 May; 42(7-8):742-5. PubMed ID: 19094978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cofactor treatment improves ATP synthetic capacity in patients with oxidative phosphorylation disorders.
    Marriage BJ; Clandinin MT; Macdonald IM; Glerum DM
    Mol Genet Metab; 2004 Apr; 81(4):263-72. PubMed ID: 15059613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oxidative stress as common pathological phenomenon and possibilities of its correction].
    Kipiani VA; Sanikidze TV; Kipiani NV; Pavliashvili NS; Kipiani NV
    Georgian Med News; 2005 Dec; (129):138-41. PubMed ID: 16444055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.